Hewitt CA - Search Results

1

Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.

Zapparoli GV, Jorissen RN, Hewitt CA, McBean M, Westerman DA, Dobrovic A. Zapparoli GV, et al. Among authors: hewitt ca. BMC Cancer. 2013 Apr 24;13:206. doi: 10.1186/1471-2407-13-206. BMC Cancer. 2013. PMID: 23617802 Free PMC article.

2

Analysing DNA methylation using bisulphite pyrosequencing.

Mikeska T, Felsberg J, Hewitt CA, Dobrovic A. Mikeska T, et al. Among authors: hewitt ca. Methods Mol Biol. 2011;791:33-53. doi: 10.1007/978-1-61779-316-5_4. Methods Mol Biol. 2011. PMID: 21913070

3

Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Blombery PA, Wong SQ, Hewitt CA, Dobrovic A, Maxwell EL, Juneja S, Grigoriadis G, Westerman DA. Blombery PA, et al. Among authors: hewitt ca. Haematologica. 2012 May;97(5):780-3. doi: 10.3324/haematol.2011.054874. Epub 2011 Dec 1. Haematologica. 2012. PMID: 22133769 Free PMC article.

4

KIT D816V mutation detection: a comparative study using peripheral blood, bone marrow aspirate and bone marrow trephine samples for detection of KIT mutations in patients with systemic mastocytosis.

Agarwal R, McBean M, Hewitt C, Westerman DA. Agarwal R, et al. Leuk Lymphoma. 2014 Sep;55(9):2202-3. doi: 10.3109/10428194.2013.876498. Epub 2014 Jan 28. Leuk Lymphoma. 2014. PMID: 24359244 No abstract available.

5

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.

Pang JB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, Hewitt C, Takano EA, Byrne DJ, Choong DY, Millar EK, Lee CS, O'Toole SA, Lakhani SR, Cummings MC, Mann GB, Campbell IG, Dobrovic A, Loi S, Gorringe KL, Fox SB. Pang JB, et al. Mod Pathol. 2017 Jul;30(7):952-963. doi: 10.1038/modpathol.2017.21. Epub 2017 Mar 24. Mod Pathol. 2017. PMID: 28338653 Free article.

6

A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma.

Richter A, Grieu F, Carrello A, Amanuel B, Namdarian K, Rynska A, Lucas A, Michael V, Bell A, Fox SB, Hewitt CA, Do H, McArthur GA, Wong SQ, Dobrovic A, Iacopetta B. Richter A, et al. Among authors: hewitt ca. Sci Rep. 2013;3:1659. doi: 10.1038/srep01659. Sci Rep. 2013. PMID: 23584600 Free PMC article.

7

Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome.

Drini M, Wong NC, Scott HS, Craig JM, Dobrovic A, Hewitt CA, Dow C, Young JP, Jenkins MA, Saffery R, Macrae FA. Drini M, et al. Among authors: hewitt ca. PLoS One. 2011 Feb 10;6(2):e16831. doi: 10.1371/journal.pone.0016831. PLoS One. 2011. PMID: 21347319 Free PMC article.

8

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting.

Whitehall V, Tran K, Umapathy A, Grieu F, Hewitt C, Evans TJ, Ismail T, Li WQ, Collins P, Ravetto P, Leggett B, Salto-Tellez M, Soong R, Fox S, Scott RJ, Dobrovic A, Iacopetta B. Whitehall V, et al. J Mol Diagn. 2009 Nov;11(6):543-52. doi: 10.2353/jmoldx.2009.090057. Epub 2009 Oct 8. J Mol Diagn. 2009. PMID: 19815694 Free PMC article.

9

Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA.

Arnolda R, Howlett K, Chan T, Raleigh J, Hatzimihalis A, Bell A, Fellowes A, Sandhu S, McArthur GA, Fox SB, Dawson SJ, Hewitt C, Jones K, Wong SQ. Arnolda R, et al. Pathology. 2022 Oct;54(6):772-778. doi: 10.1016/j.pathol.2022.02.010. Epub 2022 May 23. Pathology. 2022. PMID: 35618509

10

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, Draganic B, Smith S, Hewitt C, Philimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Ping-Chang S, Tannapfel A, Reinacher-Schick A, Uhl W, Teschendorf C, Wolters H, Stern J, Viebahn R, Friess H, Janssen KP, Nitsche U, Slotta-Huspenina J, Pohl M, Vangala D, Baraniskin A, Dockhorn-Dworniczak B, Hegewisch-Becker S, Ronga P, Edelstein DL, Jones FS, Hahn S, Fox SB. Schmiegel W, et al. Mol Oncol. 2017 Feb;11(2):208-219. doi: 10.1002/1878-0261.12023. Epub 2017 Jan 20. Mol Oncol. 2017. PMID: 28106345 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page